{
    "Trade/Device Name(s)": [
        "ACE ALT Reagent",
        "ACE AST Reagent",
        "ACE \u03b3-GT Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "k113382",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931786"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIT",
        "CKA",
        "JPZ"
    ],
    "Summary Letter Date": "June 19, 2012",
    "Summary Letter Received Date": "June 20, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR \u00a7862.1100"
    ],
    "Regulation Name(s)": [
        "Aspartate amino transferase (AST/SGOT) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Alanine aminotransferase (ALT)",
        "Aspartate aminotransferase (AST)",
        "Gamma-glutamyltransferase (\u03b3-GT)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "NADH Oxidation/NAD Reduction (for ALT and AST)",
        "Colorimetric Method (for \u03b3-GT)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ACE ALT, AST, and \u03b3-GT reagents on the ACE Axcel Clinical Chemistry System for serum enzyme quantification.",
    "Indications for Use Summary": "For quantitative determination of ALT, AST, and \u03b3-GT activities in serum using the ACE Axcel Clinical Chemistry System to aid in the diagnosis and treatment of liver and heart diseases; for in vitro diagnostic use in clinical and physician office laboratories.",
    "fda_folder": "Clinical Chemistry"
}